Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trial

The Lancet Oncology 2026

View at publisher
Authors: Natalie Y L Ngoi, Jung-Yun Lee, Diana Lim, Yee Liang Thian, Yi Wan Lim, Jack J Chan, Wen Yee Chay, Z. Zhang, Anil Gopinathan, Siew Eng Lim, Jeffrey Low, Joseph Ng
+10 more Pearl Tong, Yong-Jae Lee, Junsik Park, Jae-Weon Kim, Tuan Zea Tan, Junxian Zhu, Bee Choo Tai, Chel Hun Choi, Byoung-Gie Kim, D TAN
DOI: 10.1016/s1470-2045(25)00662-x
Cited by: 6
References: 30

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Ovarian cancer diagnosis and treatment Ferroptosis and cancer prognosis

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
2
Pages
201–211
Publication date
15 January 2026
Language
EN